Treatment of acute myeloid leukaemia in pregnancy.
Cavenagh
J D
JD
Richardson
D S
DS
Cahill
M R
MR
Bernard
T
T
Kelsey
S M
SM
Newland
A C
AC
D000208:Acute Disease; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002408:Catheters, Indwelling / Q000009:adverse effects; D002585:Cesarean Section; D003131:Combined Modality Therapy; D005260:Female; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D007951:Leukemia, Myeloid / Q000628:therapy*; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000209:etiology / Q000628:therapy; D011252:Pregnancy Complications, Neoplastic / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012074:Remission Induction; D013203:Staphylococcal Infections / Q000209:etiology / Q000628:therapy; D013212:Staphylococcus epidermidis
D000900:Anti-Bacterial Agents; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim